EverSource Wealth Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History

EverSource Wealth Advisors’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09K	Hold	407	–	–	﹤0.01%	3936
2026 Q1	$961	Hold	407	–	–	﹤0.01%	3867
2025 Q4	$859	Hold	407	–	–	﹤0.01%	3748
2025 Q3	$696	Sell	407 -8	-2%	-$11	﹤0.01%	3854
2025 Q2	$481	Sell	415 -71	-15%	-$76	﹤0.01%	3910
2025 Q1	$535	Buy	+486	New	+$694	﹤0.01%	3436

Other funds holding ABOS

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Clune & Associates Chicago, Illinois $661M AUM 21.51% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

TFM

TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

EverSource Wealth Advisors's ABOS Position: Q2 2026 in Review

EverSource Wealth Advisors held its Acumen Pharmaceuticals (ABOS) position steady in Q2 2026 at 407 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #3936.

EverSource Wealth Advisors first reported a position in ABOS in Q1 2025 and has held it in 6 quarters since. 10 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

EverSource Wealth Advisors held 407 shares of Acumen Pharmaceuticals worth $1.09K as of Q2 2026.
EverSource Wealth Advisors left its Acumen Pharmaceuticals share count unchanged in Q2 2026.
Acumen Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3936 holding.
EverSource Wealth Advisors first reported a position in Acumen Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
10 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.